As of Apr 2, 2025, the Lantheus Holdings stock's PE ratio is 21.55. This takes into account the latest EPS of $4.52 and stock price of $97.42. The PE ratio has increased by 45% from its last 4 quarters average of 14.9.
The PE ratio of Lantheus Holdings has averaged 37.67 over the last nine years. The current price-to-earnings ratio of 21.55 is 43% less than the historical average. Analyzing the last nine years, LNTH's PE ratio reached its highest point in the Jun 2023 quarter at 171.27, when the price was $83.92 and the EPS was $0.49. The lowest point was recorded in the Jun 2016 quarter, when it reached 3.71 with a price of $3.67 and an EPS of $0.99.
Maximum annual increase: 138.83% in 2018
Maximum annual decrease: -89.59% in 2023
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 19.79 | 52.94% | $89.46 | $4.52 |
2023 | 12.94 | -89.59% | $62 | $4.79 |
2022 | 124.29 | N/A | $50.96 | $0.41 |
2021 | N/A | N/A | $28.89 | -$1.06 |
2020 | N/A | N/A | $13.49 | -$0.25 |
2019 | 25.32 | 71.54% | $20.51 | $0.81 |
2018 | 14.76 | 138.83% | $15.65 | $1.06 |
2017 | 6.18 | -39.65% | $20.45 | $3.31 |
2016 | 10.24 | N/A | $8.6 | $0.84 |
2015 | N/A | N/A | $3.38 | -$0.6 |
2014 | N/A | N/A | N/A | -$0.2 |
2013 | N/A | N/A | N/A | -$3.42 |
2012 | N/A | N/A | N/A | -$0.84 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 19.79 | 12% | $89.46 | $4.52 |
Sep 2024 | 17.67 | 37.51% | $109.75 | $6.21 |
Jun 2024 | 12.85 | 39.22% | $80.29 | $6.25 |
Mar 2024 | 9.23 | -28.67% | $62.24 | $6.74 |
Dec 2023 | 12.94 | -71.5% | $62 | $4.79 |
Sep 2023 | 45.41 | -73.49% | $69.48 | $1.53 |
Jun 2023 | 171.27 | N/A | $83.92 | $0.49 |
Mar 2023 | N/A | N/A | $82.56 | -$0.26 |
Dec 2022 | 124.29 | 173.95% | $50.96 | $0.41 |
Sep 2022 | 45.37 | -68.39% | $70.33 | $1.55 |
Jun 2022 | 143.54 | N/A | $66.03 | $0.46 |
Mar 2022 | N/A | N/A | $55.31 | -$0.56 |
Dec 2021 | N/A | N/A | $28.89 | -$1.06 |
Sep 2021 | N/A | N/A | $25.68 | -$0.51 |
Jun 2021 | N/A | N/A | $27.64 | -$0.41 |
LNTH's current PE ratio is under its 3 and 5-year averages.
LNTH's PE ratio is less than its peer stock IDXX, but it is above ABT's.
Stock name | PE ratio | Market cap |
---|---|---|
ABT Abbott Laboratories | 17.2 | $228.86B |
LNTH Lantheus Holdings Inc | 21.66 | $6.71B |
IDXX Idexx Laboratories Inc | 38.16 | $33.42B |
CTSO Cytosorbents Corp | N/A | $61.88M |
LNTH stock has a price to earnings ratio of 21.55 as of Apr 2, 2025.
The average PE ratio for LNTH stock over the past 3 years is 60.24.
The average PE ratio for LNTH stock over the past 5 years is 67.37.
The highest quarterly PE ratio in the last nine years has been 171.27 and it was in the Jun 2023 quarter.
LNTH's price to earnings ratio is currently 43% below its 9-year historical average.
The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Apr 2, 2025), Lantheus Holdings's share price is $97.42. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $4.52. Therefore, Lantheus Holdings's price to earnings ratio for today is 21.55. PE RATIO(21.55) = STOCK PRICE($97.42) / TTM EPS($4.52)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.